Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patientsMatthew R. Wilson, Fiona Miall, Matthew J. Ahearne et al.|UCL Discovery (University College London)|2022Cited by 76
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibility and efficacy in routine clinical practiceElisabeth Schorb, Andrés J.M. Ferreri, Christopher P. Fox et al.|British Journal of Haematology|2020Cited by 69
Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAndrés J.M. Ferreri, M. Dreyling, Gerald Illerhaus et al.|Annals of Oncology|2024Cited by 46
Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐upAndrés J. M. Ferreri, Martin Dreyling, Gerald Illerhaus et al.|HemaSphere|2024Cited by 26